303 related articles for article (PubMed ID: 21242691)
21. MRI and cognitive impairment in Parkinson's disease.
Ibarretxe-Bilbao N; Tolosa E; Junque C; Marti MJ
Mov Disord; 2009; 24 Suppl 2():S748-53. PubMed ID: 19877242
[TBL] [Abstract][Full Text] [Related]
22. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
Galtier I; Nieto A; Lorenzo JN; Barroso J
J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
[TBL] [Abstract][Full Text] [Related]
23. Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study).
Reid WG; Hely MA; Morris JG; Loy C; Halliday GM
J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):1033-7. PubMed ID: 21335570
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
[TBL] [Abstract][Full Text] [Related]
25. Apathy may herald cognitive decline and dementia in Parkinson's disease.
Dujardin K; Sockeel P; Delliaux M; Destée A; Defebvre L
Mov Disord; 2009 Dec; 24(16):2391-7. PubMed ID: 19908317
[TBL] [Abstract][Full Text] [Related]
26. Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease.
Charissé D; Erus G; Pomponio R; Gorges M; Schmidt N; Schneider C; Liepelt-Scarfone I; Riedel O; Reetz K; Schulz JB; Berg D; Storch A; Witt K; Dodel R; Kalbe E; Kassubek J; Hilker-Roggendorf R; Baudrexel S
Neurobiol Aging; 2022 Jan; 109():31-42. PubMed ID: 34649002
[TBL] [Abstract][Full Text] [Related]
27. A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease.
Meyer A; Handabaka I; Ehrensperger MM; Gschwandtner U; Hatz F; Monsch AU; Stieglitz RD; Fuhr P
Dement Geriatr Cogn Disord; 2020; 49(2):170-178. PubMed ID: 32634809
[TBL] [Abstract][Full Text] [Related]
28. Cognitive profiles in dementia: Alzheimer disease vs healthy brain aging.
Johnson DK; Storandt M; Morris JC; Langford ZD; Galvin JE
Neurology; 2008 Nov; 71(22):1783-9. PubMed ID: 19029518
[TBL] [Abstract][Full Text] [Related]
29. Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.
Nombela C; Rowe JB; Winder-Rhodes SE; Hampshire A; Owen AM; Breen DP; Duncan GW; Khoo TK; Yarnall AJ; Firbank MJ; Chinnery PF; Robbins TW; O'Brien JT; Brooks DJ; Burn DJ; ; Barker RA
Brain; 2014 Oct; 137(Pt 10):2743-58. PubMed ID: 25080285
[TBL] [Abstract][Full Text] [Related]
30. A neuropsychological comparison of demented and nondemented patients with Parkinson's disease.
Zakzanis KK; Freedman M
Appl Neuropsychol; 1999; 6(3):129-46. PubMed ID: 10497689
[TBL] [Abstract][Full Text] [Related]
31. CERAD test performance and cognitive impairment in Parkinson's disease.
Karrasch M; Laatu S; Martikainen K; Marttila R
Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
[TBL] [Abstract][Full Text] [Related]
32. The influence of vascular risk factors on cognitive function in early Parkinson's disease.
Doiron M; Langlois M; Dupré N; Simard M
Int J Geriatr Psychiatry; 2018 Feb; 33(2):288-297. PubMed ID: 28509343
[TBL] [Abstract][Full Text] [Related]
33. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
[TBL] [Abstract][Full Text] [Related]
34. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability.
Cooper JA; Sagar HJ; Jordan N; Harvey NS; Sullivan EV
Brain; 1991 Oct; 114 ( Pt 5)():2095-122. PubMed ID: 1933236
[TBL] [Abstract][Full Text] [Related]
35. Paired Studies Comparing Clinical Profiles of Lewy Body Dementia with Alzheimer's and Parkinson's Diseases.
Scharre DW; Chang SI; Nagaraja HN; Park A; Adeli A; Agrawal P; Kloos A; Kegelmeyer D; Linder S; Fritz N; Kostyk SK; Kataki M
J Alzheimers Dis; 2016 Oct; 54(3):995-1004. PubMed ID: 27567844
[TBL] [Abstract][Full Text] [Related]
36. Cognitive slowing in Parkinson's and Alzheimer's patients: distinguishing bradyphrenia from dementia.
Pate DS; Margolin DI
Neurology; 1994 Apr; 44(4):669-74. PubMed ID: 8164823
[TBL] [Abstract][Full Text] [Related]
37. Neuropsychological characteristics of preclinical dementia in Parkinson's disease.
Jacobs DM; Marder K; Côté LJ; Sano M; Stern Y; Mayeux R
Neurology; 1995 Sep; 45(9):1691-6. PubMed ID: 7675228
[TBL] [Abstract][Full Text] [Related]
38. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
[TBL] [Abstract][Full Text] [Related]
39. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
40. Verbal and visuospatial deficits in dementia with Lewy bodies.
Johnson DK; Morris JC; Galvin JE
Neurology; 2005 Oct; 65(8):1232-8. PubMed ID: 16247050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
